A monoclonal antibody (145-2C11) specific for the murine T3 complex was developed by immunizing Armenian hamsters with a murine cytolytic T-cell clone. This antibody specifically recognizes a 25-kDa protein component (T3-ε) of the antigen-specific T-cell receptor (TCR). It reacts with all mature T cells and can both activate and inhibit T-cell function, indicating that T3-ε is involved in transducing activation signals. T-cell activation requires both antigen recognition through MHC proteins and transmembrane signaling. The TCR is a disulfide-linked heterodimer of α and β chains, and the T3 complex is an invariant protein complex associated with the TCR. The human T3 complex includes T3-δ, T3-γ, and T3-ε, while the murine T3 complex includes T3-δ, T3-ε, T3-γ, and T3-ζ. The T3 proteins are involved in transmembrane signaling, with T3-ε being a key component. The study identified a monoclonal antibody specific for the murine T3 complex, which reacts with T3-ε, a 25-kDa protein associated with the TCR. This antibody was generated by immunizing hamsters with a T-cell clone and was characterized through flow cytometry and biochemical analysis. The antibody was shown to react with T3-ε, a component of the TCR-T3 complex, and to have functional properties similar to anti-human T3-δ antibodies. The antibody was tested for its ability to activate and inhibit T-cell function. It was found to activate T-cell proliferation and induce lysis of target cells, indicating its role in T-cell activation. The antibody also showed the ability to redirect lysis of effector CTLs to non-antigen-bearing targets, suggesting its involvement in T-cell signaling. The study concludes that the monoclonal antibody 145-2C11 is specific for T3-ε and can serve as either an agonist or antagonist in T-cell activation. This antibody will be useful in studying the role of various components of the TCR complex in T-cell activation and development, as well as the expression of other TCR gene products associated with T3 polypeptides. The antibody also allows the development of an animal model to investigate the immunoregulatory effects of in vivo administration of anti-T3 antibodies.A monoclonal antibody (145-2C11) specific for the murine T3 complex was developed by immunizing Armenian hamsters with a murine cytolytic T-cell clone. This antibody specifically recognizes a 25-kDa protein component (T3-ε) of the antigen-specific T-cell receptor (TCR). It reacts with all mature T cells and can both activate and inhibit T-cell function, indicating that T3-ε is involved in transducing activation signals. T-cell activation requires both antigen recognition through MHC proteins and transmembrane signaling. The TCR is a disulfide-linked heterodimer of α and β chains, and the T3 complex is an invariant protein complex associated with the TCR. The human T3 complex includes T3-δ, T3-γ, and T3-ε, while the murine T3 complex includes T3-δ, T3-ε, T3-γ, and T3-ζ. The T3 proteins are involved in transmembrane signaling, with T3-ε being a key component. The study identified a monoclonal antibody specific for the murine T3 complex, which reacts with T3-ε, a 25-kDa protein associated with the TCR. This antibody was generated by immunizing hamsters with a T-cell clone and was characterized through flow cytometry and biochemical analysis. The antibody was shown to react with T3-ε, a component of the TCR-T3 complex, and to have functional properties similar to anti-human T3-δ antibodies. The antibody was tested for its ability to activate and inhibit T-cell function. It was found to activate T-cell proliferation and induce lysis of target cells, indicating its role in T-cell activation. The antibody also showed the ability to redirect lysis of effector CTLs to non-antigen-bearing targets, suggesting its involvement in T-cell signaling. The study concludes that the monoclonal antibody 145-2C11 is specific for T3-ε and can serve as either an agonist or antagonist in T-cell activation. This antibody will be useful in studying the role of various components of the TCR complex in T-cell activation and development, as well as the expression of other TCR gene products associated with T3 polypeptides. The antibody also allows the development of an animal model to investigate the immunoregulatory effects of in vivo administration of anti-T3 antibodies.